{"id":2721,"date":"2023-09-23T14:34:14","date_gmt":"2023-09-23T12:34:14","guid":{"rendered":"https:\/\/solmed-clinic.com\/?post_type=ispitivanja&p=2721"},"modified":"2024-03-30T14:20:46","modified_gmt":"2024-03-30T13:20:46","slug":"atopic-dermatitis-pediatric-patients","status":"publish","type":"ispitivanja","link":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/","title":{"rendered":"Atopic Dermatitis in Children (IL-13 Study)"},"content":{"rendered":"

Location: Solmed Polyclinic (Zagreb), SB Medico (Rijeka)<\/h3>\n

Study Drug:<\/strong> Biological therapy that neutralizes the pro-inflammatory molecule IL-13, primarily responsible for symptoms of atopic dermatitis. The drug is already registered for treating atopic dermatitis in patients older than 12 years.<\/p>\n

Main Inclusion Criteria:<\/strong> Children aged 6 months to 12 years diagnosed with atopic dermatitis three months or more ago, who, despite standard therapy, have insufficiently controlled disease.<\/p>\n

Status: In preparation<\/span><\/h3>\n

Start of Patient Enrollment: September 2024.<\/p>\n","protected":false},"excerpt":{"rendered":"

Study Drug: Biological therapy that neutralizes the pro-inflammatory molecule IL-13, primarily responsible for symptoms of atopic dermatitis. The drug is already registered for treating atopic dermatitis in patients older than 12 years.<\/p>\n","protected":false},"featured_media":0,"template":"","status_ispitivanja":[81],"podrucja":[112,113],"class_list":["post-2721","ispitivanja","type-ispitivanja","status-publish","hentry","status_ispitivanja-includes-patients","podrucja-allergology-and-immunology","podrucja-dermatology"],"acf":[],"yoast_head":"\nAtopic Dermatitis in Children (IL-13 Study) - Solmed Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atopic Dermatitis in Children (IL-13 Study) - Solmed Clinic\" \/>\n<meta property=\"og:description\" content=\"Study Drug: Biological therapy that neutralizes the pro-inflammatory molecule IL-13, primarily responsible for symptoms of atopic dermatitis. The drug is already registered for treating atopic dermatitis in patients older than 12 years.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Solmed Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/solmedgrupa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-30T13:20:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/\",\"url\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/\",\"name\":\"Atopic Dermatitis in Children (IL-13 Study) - Solmed Clinic\",\"isPartOf\":{\"@id\":\"https:\/\/solmed-clinic.com\/#website\"},\"datePublished\":\"2023-09-23T12:34:14+00:00\",\"dateModified\":\"2024-03-30T13:20:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna stranica\",\"item\":\"https:\/\/solmed-clinic.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atopic Dermatitis in Children (IL-13 Study)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solmed-clinic.com\/#website\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"name\":\"Solmed Clinic\",\"description\":\"Solutions in medicine\",\"publisher\":{\"@id\":\"https:\/\/solmed-clinic.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solmed-clinic.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solmed-clinic.com\/#organization\",\"name\":\"Solmed Clinic\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"width\":482,\"height\":77,\"caption\":\"Solmed Clinic\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/solmedgrupa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atopic Dermatitis in Children (IL-13 Study) - Solmed Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/","og_locale":"en_US","og_type":"article","og_title":"Atopic Dermatitis in Children (IL-13 Study) - Solmed Clinic","og_description":"Study Drug: Biological therapy that neutralizes the pro-inflammatory molecule IL-13, primarily responsible for symptoms of atopic dermatitis. The drug is already registered for treating atopic dermatitis in patients older than 12 years.","og_url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/","og_site_name":"Solmed Clinic","article_publisher":"https:\/\/www.facebook.com\/solmedgrupa","article_modified_time":"2024-03-30T13:20:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/","url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/","name":"Atopic Dermatitis in Children (IL-13 Study) - Solmed Clinic","isPartOf":{"@id":"https:\/\/solmed-clinic.com\/#website"},"datePublished":"2023-09-23T12:34:14+00:00","dateModified":"2024-03-30T13:20:46+00:00","breadcrumb":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/atopic-dermatitis-pediatric-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna stranica","item":"https:\/\/solmed-clinic.com\/en\/"},{"@type":"ListItem","position":2,"name":"Atopic Dermatitis in Children (IL-13 Study)"}]},{"@type":"WebSite","@id":"https:\/\/solmed-clinic.com\/#website","url":"https:\/\/solmed-clinic.com\/","name":"Solmed Clinic","description":"Solutions in medicine","publisher":{"@id":"https:\/\/solmed-clinic.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solmed-clinic.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solmed-clinic.com\/#organization","name":"Solmed Clinic","url":"https:\/\/solmed-clinic.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","width":482,"height":77,"caption":"Solmed Clinic"},"image":{"@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/solmedgrupa"]}]}},"_links":{"self":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/2721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja"}],"about":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/types\/ispitivanja"}],"version-history":[{"count":3,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/2721\/revisions"}],"predecessor-version":[{"id":3344,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/2721\/revisions\/3344"}],"wp:attachment":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media?parent=2721"}],"wp:term":[{"taxonomy":"status_ispitivanja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/status_ispitivanja?post=2721"},{"taxonomy":"podrucja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/podrucja?post=2721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}